Site Map

Biometrics »

Risk Assessment Plays Key Role In Long-term Treatment Of Breast Cancer

Thu, 14 Aug 2008 Similar Items Print Press Release Submissions »

M. D. Anderson-led team finds five-year survivors may benefit from additional therapy - Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk asse… Read »

 

Similar Items:
Using Magenetic Nanoparticles To Combat CancerUsing Magenetic Nanoparticles To Combat Cancer
Mit Researchers Demonstrate Protective Role Of MicrornaMit Researchers Demonstrate Protective Role Of Microrna
Large-scale Genetic Study Sheds New Light On Lung Cancer, Opens Door To Individualized Treatment StrategiesLarge-scale Genetic Study Sheds New Light On Lung Cancer, Opens Door To Individualized Treatment Strategies
Rna Shown To Silence Cancer Suppressor GeneRna Shown To Silence Cancer Suppressor Gene
Emsl Analytical & La Testing Distributing Relle Cassettes At IAQA’S Annual ConferenceEmsl Analytical & La Testing Distributing Relle Cassettes At IAQA’S Annual Conference
Labcorp Presents Positive Results On Gst-pi/apc Methylation Test For Detection Of Prostate CancerLabcorp Presents Positive Results On Gst-pi/apc Methylation Test For Detection Of Prostate Cancer
Develogen Announces Completion Of A Phase 1 Clinical Trial Of DG3173, A Novel Somatostatin Analogue For The Treatment Of AcromegalyDevelogen Announces Completion Of A Phase 1 Clinical Trial Of DG3173, A Novel Somatostatin Analogue For The Treatment Of Acromegaly
Abbott Announces Humira® (adalimumab) Approved In Japan For The Treatment Of Rheumatoid ArthritisAbbott Announces Humira® (adalimumab) Approved In Japan For The Treatment Of Rheumatoid Arthritis
Roche Announces Topline Outcomes For Avastin-tarceva Combination Study In Advanced Lung CancerRoche Announces Topline Outcomes For Avastin-tarceva Combination Study In Advanced Lung Cancer
Combination Therapy Packs One-two Punch Against MelanomaCombination Therapy Packs One-two Punch Against Melanoma